In addition, JAG1, a potent downstream mediator of TGFB1, which promotes osteolysis in breast cancer cells by activating the NOTCH signaling pathway, leads to increased IL6 expression (Sethi et al., 2011; Tao et al., 2011). Here, JAG1 is linked to breast carcinoma.